Ads
related to: the 23andme
Search results
Earnings call: 23andMe reviews strategic options amid revenue decline By Investing.com
Investing.com· 13 hours ago23andMe Holding Co. (ME) disclosed a strategic review to enhance shareholder value and a potential...
23andMe Gains as Revenue Beats Despite Flagging DNA Sales
Bloomberg· 1 day agoDNA testing firm 23andMe Holding Co. reported fourth-quarter revenue that beat Wall Street estimates...
TD Cowen bullish on 23andMe shares on Q4 revenue beat, strategic review By Investing.com
Investing.com· 12 hours agoOn Friday, shares of 23andMe Holding Co. (NASDAQ:ME) shares experienced an uptick in after-hours...
23andMe Fiscal Q4 Revenues Drop 31 Percent as Research Services, Genetic Test Kit Sales Shrink
GenomeWeb News· 1 day agoNEW YORK – 23andMe reported after the close of market Thursday a year-over-year revenue loss of 31 percent for its fiscal 2024 fourth quarter and a decrease of 27 percent ...
23andMe stock soars nearly 10% after delivering top-line beat in Q4 By Investing.com
Investing.com· 1 day agoThe company's revenue of $64.0 million exceeded the analyst consensus of $55.82 million. Despite a...
23andMe Holding Co (ME) Q4 2024 Earnings Call Transcript Highlig
Guru Focus· 17 hours agoRevenue: $64 million for Q4, $220 million for the full year, representing a 31% and 27% decrease, respectively, over the same periods in the prior year.Gross P
23andMe (ME) Q4 FY24 Earnings: Revenue Beats Estimates Despite 3
Guru Focus· 1 day agoRevenue: $64 million for Q4 FY24, exceeding analyst estimates of $55.82 million and down 31% year-over-year from $92.4 million.Annual Revenue: $219.6 million f
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 1 day agoSOUTH SAN FRANCISCO, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and biopharmaceutical company, reported its financial ...
People in the News at Illumina, Agilent, Deepull, Sphere Fluidics, Nucleai, 23andMe
GenomeWeb News· 6 hours agoIllumina has added Anna Richo, corporate senior VP and strategic adviser to the general counsel and CEO at Cargill, to its board of directors. Richo brings more than 30 years of experience as an attorney and legal executive.
Q4 2024 23andMe Holding Co. Earnings Call Transcript
Guru Focus· 1 day agoI would like to turn the call over to Ian Cooney, Senior Director of Investor Relations at 23andMe, to lead off the call. Before we begin, I encourage everyone to go to investors ...
